FATE

Fate Therapeutics Inc

Jun 05 • 04:00PM ET

1.98

-0.23 -10.41 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ALLO CCCC ALXO BCYC CLLS FHTX CHRS IMRX REPL ZNTL

| Held by: IWM VTI IWN VXF SCHA VTWO IWC PRFZ VHT DFMC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.09	Insider Own	5.17%	Shs Outstand	116.27M	Perf Week	-30.28%
Market Cap	230.79M	Forward P/E	-	EPS next Y	-0.97	Insider Trans	-1.15%	Shs Float	110.53M	Perf Month	-13.54%
Enterprise Value	132.75M	PEG	-	EPS next Q	-0.27	Inst Own	60.84%	Short Float	8.80%	Perf Quarter	48.87%
Income	-129.91M	P/S	36.52	EPS this Y	5.77%	Inst Trans	11.29%	Short Ratio	3.54	Perf Half Y	83.33%
Sales	6.32M	P/B	1.28	EPS next Y	10.30%	ROA	-38.01%	Short Interest	9.73M	Perf YTD	101.51%
Book/sh	1.55	P/C	1.32	EPS next 5Y	5.01%	ROE	-55.50%	52W High	2.88 -31.25%	Perf Year	47.76%
Cash/sh	1.50	P/FCF	-	EPS past 3/5Y	26.67% 11.42%	ROIC	-51.60%	52W Low	0.91 117.58%	Perf 3Y	-61.63%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-58.98% -26.71%	Gross Margin	-97.69%	Volatility	11.57% 12.84%	Perf 5Y	-97.28%
Dividend TTM	-	EV/Sales	21.00	EPS Y/Y TTM	26.97%	Oper. Margin	-2207.47%	ATR (14)	0.25	Perf 10Y	22.22%
Dividend Ex-Date	-	Quick Ratio	5.85	Sales Y/Y TTM	-52.64%	Profit Margin	-2056.79%	RSI (14)	47.17	Recom	1.91
Dividend Gr. 3/5Y	- -	Current Ratio	5.85	EPS Q/Q	18.19%	SMA20	-10.27%	Beta	2.54	Target Price	5.41
Payout	-	Debt/Eq	0.43	Sales Q/Q	-20.26%	SMA50	14.69%	Rel Volume	1.41	Prev Close	2.21
Employees	161	LT Debt/Eq	0.40	Earnings	May 13 BMO	SMA200	50.85%	Avg Volume	2.75M	Price	1.98
IPO	Oct 01, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.14% -12.93%	Trades		Volume	3,880,369	Change	-10.41%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)